Aniracetam

weak data

Also seen as: Ampamet, Draganon, Sarpul, Memodrin, Ro 13-5057, ani

The Dose Guy’s verdict
Sep 1, 2026
5 sources

The racetam people reach for when the goal is mood and verbal fluency alongside focus. Aniracetam has a real AMPA-receptor mechanism, a handful of human trials in elderly and impaired populations, and a community that swears by the anxiolytic edge. The honest picture: the human data is old and thin, no trial has shown a benefit in unimpaired cognition, and controlled animal work in healthy mice found nothing. What you are buying is a well-characterized mechanism, decades of community experience, and the chance that the subjective reports reflect something real. Know what you are buying literally, too: lab testing of cognitive supplements found 9 of 12 declared drug quantities inaccurate and undeclared drugs in the mix, with one product delivering up to 502 mg of aniracetam per serving to users following its label. That is more than most of this shelf offers. It is not proof, and the supply chain is a mess.

Would I take it?Maybe, if you know what you're buying.

What it is

A fat-soluble racetam, the second-generation cousin of piracetam, and a positive modulator of AMPA receptors, the fast excitatory channels that carry most of the moment-to-moment signaling in your cortex. In electrophysiology work, aniracetam slows the rate at which AMPA channels close and desensitize, effectively stretching each signal. The anxiolytic and verbal-fluency reputation that sets it apart from other racetams probably traces to this, though the exact pathway from receptor kinetics to “conversations feel easier” is not pinned down.

On the nootropic shelf it sits in the middle: more mechanism data than most racetams, less clinical data than you’d want, and a community following built largely on how it feels. Pair it with alpha-GPC or another choline source, because racetams increase acetylcholine turnover and a headache from choline depletion is the most common beginner mistake.

What the research shows

Old human trials, mixed results in impaired populations, and a conspicuous silence in healthy subjects:

In 109 patients with mild to moderate Alzheimer’s, the aniracetam group improved on psychobehavioral measures over 6 months while the placebo group steadily deteriorated. The abstract reports significance but no effect size.Eur Neuropsychopharmacol 1991 · RCT · n=109
In 44 patients with Alzheimer-type senile dementia, aniracetam 1 g daily for 3 months produced no clinical efficacy difference from placebo. Same indication as the 1991 trial, opposite result.Psychopharmacology 1987 · RCT · n=44
In 44 people with chronic psychosyndrome after solvent exposure, aniracetam 1 g daily for 3 months did not improve overall condition or neuropsychological symptoms.J Neural Transm 1990 · crossover · n=44
In 26 healthy volunteers given scopolamine to impair cognition, 1500 mg of aniracetam significantly rescued decrements in memory and information-processing tasks.J Psychopharmacol 1990 · crossover · n=26
In healthy adult mice, daily aniracetam at 50 mg/kg produced no significant difference from placebo across cognitive, motor, anxiety, and locomotor measures.PLoS ONE 2014 · animal

Realistic protocols

Take it with fat. Aniracetam is fat-soluble and absorbs poorly without it, so dosing with a meal or at least a spoonful of oil is not optional, it is the difference between aniracetam working and not working. The parent compound clears fast, which is why most people split their dose across the day rather than taking one large hit.

The standard community protocol is 750 mg twice daily, 1500 mg total, with some people adding a midday dose for a smoother curve. Start at the lower end and see how the anxiolytic edge shows up for you before climbing. Pair it with a choline source from day one. If you get headaches, the choline dose is probably the issue, not the aniracetam.

Standard750 mg 2x/dayMorning and afternoon, with food containing fat. The split matters.
Full stack750 mg 3x/dayMorning, midday, afternoon. Smoother coverage, same logic.
Choline+ alpha-GPC300 mg alpha-GPC with each dose. Prevents the racetam headache.
AssessmentYour doseGive it 2 to 4 weeks. The anxiolytic effect is often clearer than the cognitive one.

Side effects

Generally mild, and the most common complaint is actually choline depletion from running it without a source:

commonConfusion interrupted treatment in four aniracetam recipients and one placebo recipient in a 44-patient Alzheimer’s trial. The one trial-documented adverse event on the sheet.
anecdotalHeadache, the racetam tell. Almost always from insufficient choline intake. Add a choline source before blaming the aniracetam.
anecdotalGI discomfort, more likely on an empty stomach or without fat. Take it with food.
anecdotalIrritability or restlessness at higher doses, reported by a minority. Dose reduction resolves it.
unknownNo long-term safety data in healthy people taking it for enhancement. The RCTs run 3 to 6 months in elderly and impaired populations, with one 12-month open-label follow-up. What decades of continuous racetam use does is an open question.

Where to buy

$0.63 / 500mg vial$0.001/mg
✓ verified Sep 12
$64.99 / unit
⚠ ⚠ Unreachable since Sep 11
✓ verified Sep 8

Prices move. Links are affiliate links; they never change a ranking, and scores are set before the deal exists.